Report Discusses Possibilities in Pipeline for Cardiovascular Pacing and Implantable Cardioverter-defibrillator (ICD) Leads

Published Date : Jun 27, 2016

ALBANY, NY, June 27, 2016: has added a new research report to its expansive collection of the latest market intelligence documents on the global medical equipment industry. The report, titled “Cardiovascular Pacing And Implantable Cardioverter-Defibrillator (ICD) Leads - Medical Devices Pipeline Assessment, 2016,” focuses on the pipeline specifically to draw valuable conclusions on how the future of this market will be shaped. 

The report provide an overview of the cardiovascular pacing and ICD leads pipeline as well as a detailed description of specific names.

Cardiac pacing is the use of external devices to temporarily control the pace of a human heart. They can be life-saving devices in times of emergencies. Cardiac pacers usually pass an electric pulse through a patient’s chest, therefore stimulating contractions in the heart. Simultaneous contractions can simulate a heartbeat and help regulate it.

Implantable cardioverter defibrillators have proven to be highly valuable in saving lives in the event of sudden death in patients that are already diagnosed with sustained ventricular fibrillation or ventricular tachycardia. Typical ICDs are powered by a battery which and are located right under the skin in a position where it can monitor a patient’s heart rate. If the ICD sensors detect any irregular functioning of the heart, it will send an electric shock to regulate the heartbeat. The most common cases where ICDs are used include patients with an electrolyte imbalance or drug toxicity, myocardial ischemia, or acute myocardial infarction.

The report on the cardiovascular pacing and ICD leads pipeline creates a holistic analytical picture that includes data on the key pipeline products still in development. This information includes the current trials that are in progress, the phase of each trial, the number of trials, their status, and the start and end dates for each trial.

For Sample Copy, click here:

To achieve this, the report’s authors derive data from an in-house information pool collected over the years, along with secondary and primary research methods for the latest information generated.

The report also provides a descriptive reports of the cardiovascular pacing and ICD leads pipeline and all the key players involved. These include Teleflex Incorporated, St. Jude Medical, Inc., MRI Interventions, Inc., MicroPort Scientific Corporation, Medtronic Plc., Mayo Clinic U.S., LivaNova Plc., Imricor Medical Systems, Inc., and Boston Scientific Corporation.

Apart from a key player reports, the report also discusses the latest news events for the cardiovascular pacing and ICD leads pipeline. Some of the top new report analyses presented include market consolidation reports. For instance, the report discusses the implications of the acquisition planned by Abbott Labs over St. Jude Medical, which is expected to occur for nearly US$24 bn. The report also talk about the financial reports of each player, coupled with a review of the proposed regulations, whether they are temporary or permanent.

To order report Call Toll Free: 866-997-4948 or send an email on